FILSUVEZ
- Active Ingredient(s): Birch Triterpenes
- Strength: 10%
- Dosage Form(s) / Route(s): Gel;topical
- Company: Amryt
- Approval Date: 18 December 2023
- Submission Classification: Type 1 - New Molecular Entity
- Indication(s): Indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa in adult and pediatric patients 6 months of age and older.
- Approved Label: 18 December 2023 (PDF)
- Active Ingredient(s): Eplontersen Sodium
- Strength: 45MG/0.8ML
- Dosage Form(s) / Route(s): Injectable;injection
- Company: Ionis Pharma Inc
- Approval Date: 21 December 2023
- Submission Classification: Type 1 - New Molecular Entity
- Indication(s): Indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
- Approved Label: 21 December 2023 (PDF)